# Regulatory & Compliance Episodes of The Dime Podcast covering Regulatory & Compliance: cannabis business conversations with founders, executives and investors. 57 episodes. - Canonical: https://www.dimepodcast.com/topics/regulatory-and-compliance - Topic index for agents: https://www.dimepodcast.com/topics/regulatory-and-compliance/llms.txt - All topics: https://www.dimepodcast.com/topics ## Analysis on Regulatory & Compliance First Principles essays by Bryan Fields. Human written. - [The Best Advantage Is Scar Tissue](https://www.dimepodcast.com/newsletter/the-best-advantage-is-scar-tissue) (October 26, 2026): Capital can buy equipment, but not years of mistakes already turned into systems and judgment. Why the best cannabis advantage may be what a company survived somewhere else. Markdown: https://www.dimepodcast.com/newsletter/the-best-advantage-is-scar-tissue.md - [The Best Asset Is the One That Survives Being Wrong](https://www.dimepodcast.com/newsletter/the-best-asset-is-the-one-that-survives-being-wrong) (October 14, 2026): Reform does not help every cannabis operator equally. Jay Rosenthal on why the best asset is the one that still has value when your forecast is wrong. Markdown: https://www.dimepodcast.com/newsletter/the-best-asset-is-the-one-that-survives-being-wrong.md - [Curaleaf x Aurora: Why EU-GMP Is the Hidden Asset in the Deal](https://www.dimepodcast.com/newsletter/curaleaf-aurora-why-eu-gmp-is-the-hidden-asset-in-the-deal) (September 22, 2026): Curaleaf's pursuit of Aurora isn't really about cannabis. It's about 50+ tons of EU-GMP supply and the two years it takes to build it from scratch. Markdown: https://www.dimepodcast.com/newsletter/curaleaf-aurora-why-eu-gmp-is-the-hidden-asset-in-the-deal.md - [The Cannabis Industry Fought for Medical Access. Why Is It Silent Now?](https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now) (August 4, 2026): The federal hemp ban arrives in November. It was aimed at intoxicating products, but the language is broad enough to take therapeutic CBD with it. Markdown: https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now.md - [The Payment Problem I Still Can't Explain](https://www.dimepodcast.com/newsletter/the-payment-problem-i-still-cant-explain) (April 13, 2026): Cannabis banking's hardest problem: compliance does not equal permission. Every payment solution runs on the card brands' tolerance. Markdown: https://www.dimepodcast.com/newsletter/the-payment-problem-i-still-cant-explain.md - [Let's End the Year of the Prohibitionist.](https://www.dimepodcast.com/newsletter/lets-end-the-year-of-the-prohibitionist) (April 3, 2026): Access is a transaction. Influence is leverage. Cannabis has confused the two, and the scoreboard in Washington keeps saying so. Markdown: https://www.dimepodcast.com/newsletter/lets-end-the-year-of-the-prohibitionist.md - [Your Neighbor Is Destroying Your Supply Chain](https://www.dimepodcast.com/newsletter/your-neighbor-is-destroying-your-supply-chain) (March 11, 2026): Pesticide drift means a cannabis team can do everything right and still fail testing. Vertical integration as environmental defense. Markdown: https://www.dimepodcast.com/newsletter/your-neighbor-is-destroying-your-supply-chain.md - [Before CBD Was a Category, It Was a Medical Necessity](https://www.dimepodcast.com/newsletter/before-cbd-was-a-category-it-was-a-medical-necessity) (January 13, 2026): CBD didn't earn acceptance through branding. It earned it because results showed up where nothing else worked — and Schedule III raises the bar again. Markdown: https://www.dimepodcast.com/newsletter/before-cbd-was-a-category-it-was-a-medical-necessity.md - [CBD: The Gateway Cannabinoid](https://www.dimepodcast.com/newsletter/cbd-the-gateway-cannabinoid) (December 22, 2025): Schedule III put CBD first for a reason: it's the lowest-friction entry point for FDA oversight. The agency will apply the playbook it knows. Markdown: https://www.dimepodcast.com/newsletter/cbd-the-gateway-cannabinoid.md - [The Enemy of My Enemy Is My Friend, Except When It Comes to Cannabinoids](https://www.dimepodcast.com/newsletter/the-enemy-of-my-enemy-is-my-friend-except-when-it-comes-to-cannabinoids) (October 3, 2025): Logic doesn't work in the cannabinoid space. Power and influence do. Spirits, pharma, big ag and retail are all circling the same disruption. Markdown: https://www.dimepodcast.com/newsletter/the-enemy-of-my-enemy-is-my-friend-except-when-it-comes-to-cannabinoids.md ## Episodes - [What Makes Consumers Buy the Same Edible Again? ft. Kim Sanchez Rael](https://www.dimepodcast.com/episodes/what-makes-consumers-buy-the-same-edible-again-ft-kim-sanchez-rael) — Kim Sanchez Rael: In this episode, Bryan Fields talks with Kim Sanchez Rael of Azuca about why fast-onset edibles still make up only a small slice of the cannabis market despite clear consumer demand and premium… Markdown: https://www.dimepodcast.com/episodes/what-makes-consumers-buy-the-same-edible-again-ft-kim-sanchez-rael.md - [Europe Is Not a Rescue Plan ft. Jamie Pearson](https://www.dimepodcast.com/episodes/europe-is-not-a-rescue-plan-ft-jamie-pearson) — Jamie Pearson: This episode features international cannabis strategist Jamie Pearson breaking down why Europe is a medical, pharmaceutical-grade market rather than a quick escape hatch for struggling US operators,… Markdown: https://www.dimepodcast.com/episodes/europe-is-not-a-rescue-plan-ft-jamie-pearson.md - [Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine](https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine) — Paige Figi: In this episode, Paige Figi — mother of Charlotte Figi, whose story helped launch the modern medical CBD movement — breaks down the looming November 12th federal ban on hemp-derived CBD products and… Markdown: https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine.md - [Understand This Before You Use AI To Build Software ft. Chris Guthrie](https://www.dimepodcast.com/episodes/understand-this-before-you-use-ai-to-build-software-ft-chris-guthrie) — Chris Guthrie: Chris Guthrie of 365 Cannabis joins the podcast to explain why 'vibe coding' internal ERP, CRM, and supply-chain tools with AI is a tempting but dangerous shortcut for cannabis operators, arguing… Markdown: https://www.dimepodcast.com/episodes/understand-this-before-you-use-ai-to-build-software-ft-chris-guthrie.md - [Hirsh Jain: Rescheduling Is Already Picking Winners](https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners) — Hirsh Jain: This episode features cannabis strategist Hirsh Jain unpacking the confusing reality behind the April 2025 rescheduling order — explaining why medical cannabis moved to Schedule III while adult-use… Markdown: https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners.md - [Germany Is the Engine: What BAT Knows That Cannabis Doesn't ft. James Yamanaka](https://www.dimepodcast.com/episodes/germany-is-the-engine-what-bat-knows-that-cannabis-doesnt-ft-james-yamanaka) — James Yamanaka: In this episode, Organigram CEO James Yamanaka discusses his path from British American Tobacco to leading one of Canada's largest cannabis companies, explaining how BAT's long-term, disciplined… Markdown: https://www.dimepodcast.com/episodes/germany-is-the-engine-what-bat-knows-that-cannabis-doesnt-ft-james-yamanaka.md - [Why Ohio Cannabis Is Built Different: Inside the Regulator-Operator Alignment That's Actually Working ft. Caroline Henry](https://www.dimepodcast.com/episodes/why-ohio-cannabis-is-built-different-inside-the-regulator-operator-alignment-thats-actually-working-ft-caroline-henry) — Caroline Henry: This episode features Caroline Henry of Buckeye Relief discussing why Ohio's slower, more deliberate approach to cannabis regulation — capped licensing, phased rule-making, and close collaboration… Markdown: https://www.dimepodcast.com/episodes/why-ohio-cannabis-is-built-different-inside-the-regulator-operator-alignment-thats-actually-working-ft-caroline-henry.md - [Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller](https://www.dimepodcast.com/episodes/cannabis-was-medicine-now-the-proof-is-catching-up-ft-joel-stanley-and-dr-marcel-bonn-miller) — Joel Stanley and Dr. Marcel Bonn-Miller: This episode features Joel Stanley, founding CEO of Charlotte's Web and now founder of Ozna Biosciences, and Dr. Marcel Bonn-Miller, a longtime cannabinoid researcher, discussing why proving cannabis… Markdown: https://www.dimepodcast.com/episodes/cannabis-was-medicine-now-the-proof-is-catching-up-ft-joel-stanley-and-dr-marcel-bonn-miller.md - [The Legal Market Was Never Built for Payments, Why Cannabis Still Breaks the Rules ft. Aubrey Amatelli](https://www.dimepodcast.com/episodes/the-legal-market-was-never-built-for-payments-why-cannabis-still-breaks-the-rules-ft-aubrey-amatelli) — Aubrey Amatelli: In this episode, PayRio founder Aubrey Amatelli explains why cannabis payment processing remains fundamentally unstable even for companies that follow every card-network rule, drawing on her own… Markdown: https://www.dimepodcast.com/episodes/the-legal-market-was-never-built-for-payments-why-cannabis-still-breaks-the-rules-ft-aubrey-amatelli.md - [Gretchen Gailey: Cannabis Industry Has No Idea How DC Works, Why Rescheduling Is Delayed](https://www.dimepodcast.com/episodes/gretchen-gailey-cannabis-industry-has-no-idea-how-dc-works-why-rescheduling-is-delayed) — Gretchen Gailey: Longtime Capitol Hill strategist Gretchen Gailey joins Bryan Fields to explain why the cannabis industry's Washington strategy is fundamentally broken, arguing that occasional fly-ins and small… Markdown: https://www.dimepodcast.com/episodes/gretchen-gailey-cannabis-industry-has-no-idea-how-dc-works-why-rescheduling-is-delayed.md - [Prop 64 Fine Print, Pesticide Drift, The Economics Behind Concentrates ft. Micah Anderson](https://www.dimepodcast.com/episodes/prop-64-fine-print-pesticide-drift-the-economics-behind-concentrates-ft-micah-anderson) — Micah Anderson: Micah Anderson of Leaf Brands joins Bryan Fields to dissect why California's Prop 64 rollout has left the legal cannabis market shrinking despite voter approval, and what a regulatory rewrite might… Markdown: https://www.dimepodcast.com/episodes/prop-64-fine-print-pesticide-drift-the-economics-behind-concentrates-ft-micah-anderson.md - [Cannabis Beverages Are Bringing New Consumers Into Cannabis ft Kristin & Eric Rogers](https://www.dimepodcast.com/episodes/cannabis-beverages-are-bringing-new-consumers-into-cannabis-ft-kristin-eric-rogers) — Kristin & Eric Rogers: This episode features Kristin and Eric Rogers, co-founders of cannabis beverage brand Levia, discussing how effects-based drinks are pulling new, often non-smoking consumers into cannabis. They dig… Markdown: https://www.dimepodcast.com/episodes/cannabis-beverages-are-bringing-new-consumers-into-cannabis-ft-kristin-eric-rogers.md - [How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick](https://www.dimepodcast.com/episodes/how-charlottes-web-unlocked-medical-cbd-ft-bill-morachnick) — Bill Morachnick: Charlotte's Web CEO Bill Morachnick joins The Dime to tell the origin story behind Charlotte Figi and the company's namesake, and to unpack a newly signed executive order that opens the door to… Markdown: https://www.dimepodcast.com/episodes/how-charlottes-web-unlocked-medical-cbd-ft-bill-morachnick.md - [Schedule III Changes Everything — This Is Just the Beginning](https://www.dimepodcast.com/episodes/schedule-iii-changes-everything-this-is-just-the-beginning) — Guest: This emergency episode of The Dime breaks down the same-day executive order moving cannabis toward Schedule III, featuring cannabinoid manufacturing experts Zach Edge and Matthew Moore of RHO… Markdown: https://www.dimepodcast.com/episodes/schedule-iii-changes-everything-this-is-just-the-beginning.md - [What Tobacco and Alcohol Taught Me About Cannabis. ft. Nick Kenny](https://www.dimepodcast.com/episodes/what-tobacco-and-alcohol-taught-me-about-cannabis-ft-nick-kenny) — Nick Kenny: In this episode of The Dime, hosts Bryan Fields and Kellan Finney sit down with global strategic advisor Nick Kenny, a former tobacco industry marketing executive turned cannabis consultant, to… Markdown: https://www.dimepodcast.com/episodes/what-tobacco-and-alcohol-taught-me-about-cannabis-ft-nick-kenny.md - [The Amazon of THC, How Edibles.com Will Take Cannabis National, ft. Thomas Winstanley](https://www.dimepodcast.com/episodes/the-amazon-of-thc-how-ediblescom-will-take-cannabis-national-ft-thomas-winstanley) — Thomas Winstanley: In this episode of The Dime, Bryan Fields and Kellan Finney sit down with Thomas Winstanley, who left his role building Theory Wellness's cannabis retail and product empire to launch Edibles.com, a… Markdown: https://www.dimepodcast.com/episodes/the-amazon-of-thc-how-ediblescom-will-take-cannabis-national-ft-thomas-winstanley.md - [Chris Ball: Betting It All — What It Really Takes to Build a Brand With Your Name on It: Pain, Patience, and Relentless Faith](https://www.dimepodcast.com/episodes/chris-ball-betting-it-all-what-it-really-takes-to-build-a-brand-with-your-name-on-it-pain-patience-and-relentless-faith) — Chris Ball: Chris Ball, founder and CEO of Ball Family Farms, walks through his journey from a Los Angeles legacy-market cannabis seller and felon-turned-social-equity licensee to building a family-run,… Markdown: https://www.dimepodcast.com/episodes/chris-ball-betting-it-all-what-it-really-takes-to-build-a-brand-with-your-name-on-it-pain-patience-and-relentless-faith.md - [$28.4 Billion Dollar Hemp Industry Can’t Be Put Back in the Bottle ft Jim Higdon](https://www.dimepodcast.com/episodes/284-billion-dollar-hemp-industry-cant-be-put-back-in-the-bottle-ft-jim-higdon) — Jim Higdon: This episode of The Dime features Cornbread Hemp co-founder Jim Higdon breaking down the chaotic, fast-moving fight over federal hemp policy, including a bipartisan congressional letter opposing the… Markdown: https://www.dimepodcast.com/episodes/284-billion-dollar-hemp-industry-cant-be-put-back-in-the-bottle-ft-jim-higdon.md - [Largest Medical Cannabis & Cancer Study Ever: Can These Findings Push Rescheduling? ft Ryan Castle](https://www.dimepodcast.com/episodes/largest-medical-cannabis-cancer-study-ever-can-these-findings-push-rescheduling-ft-ryan-castle) — Ryan Castle: This episode of The Dime features Ryan Castle, research director at Whole Health Oncology Institute, discussing the largest medical cannabis and cancer meta-analysis ever conducted — spanning over… Markdown: https://www.dimepodcast.com/episodes/largest-medical-cannabis-cancer-study-ever-can-these-findings-push-rescheduling-ft-ryan-castle.md - [THC Is an Ingredient, Where Pharma, MSOs & Hemp Collide, ft. Zach Edge](https://www.dimepodcast.com/episodes/thc-is-an-ingredient-where-pharma-msos-hemp-collide-ft-zach-edge) — Zach Edge: This episode of The Dime features Zach Edge — a ten-year cannabinoid industry veteran with experience spanning Folium Biosciences, Open Book Extracts, RHO Advisory, and private equity firm Suni —… Markdown: https://www.dimepodcast.com/episodes/thc-is-an-ingredient-where-pharma-msos-hemp-collide-ft-zach-edge.md - [Secrets Behind Failed Cannabis Builds: Where Every Team Needs to Look Now ft. David Fettner](https://www.dimepodcast.com/episodes/secrets-behind-failed-cannabis-builds-where-every-team-needs-to-look-now-ft-david-fettner) — David Fettner: This episode of The Dime features David Fettner, managing partner of Grow America Builders, breaking down why so many cannabis cultivation and dispensary builds go over budget or fail entirely — from… Markdown: https://www.dimepodcast.com/episodes/secrets-behind-failed-cannabis-builds-where-every-team-needs-to-look-now-ft-david-fettner.md - [Keep Your Eye on Ohio: Why California’s Failures Are Michigan’s Success, and the Global Cannabis Landscape ft. Hirsh Jain](https://www.dimepodcast.com/episodes/keep-your-eye-on-ohio-why-californias-failures-are-michigans-success-and-the-global-cannabis-landscape-ft-hirsh-jain) — Hirsh Jain: Returning guest Hirsh Jain joins Bryan Fields and Kellan Finney to dissect why California's cannabis market keeps shrinking — high taxes, city opt-outs, and a broken testing regime — while Michigan,… Markdown: https://www.dimepodcast.com/episodes/keep-your-eye-on-ohio-why-californias-failures-are-michigans-success-and-the-global-cannabis-landscape-ft-hirsh-jain.md - [Organigram’s Competitive Edge: Paolo De Luca on BAT, M&A Strategy, and the Cannabis Long Game](https://www.dimepodcast.com/episodes/organigrams-competitive-edge-paolo-de-luca-on-bat-ma-strategy-and-the-cannabis-long-game) — Paolo De Luca: Paolo De Luca, Chief Strategy Officer of Organigram, joins The Dime to break down how Canada's top cannabis company by market share is building for the long game: specialized single-category… Markdown: https://www.dimepodcast.com/episodes/organigrams-competitive-edge-paolo-de-luca-on-bat-ma-strategy-and-the-cannabis-long-game.md - [Trump, Texas SB3 & the Rescheduling Timeline: Jim Higdon on What Comes Next](https://www.dimepodcast.com/episodes/trump-texas-sb3-the-rescheduling-timeline-jim-higdon-on-what-comes-next) — Jim Higdon: Jim Higdon, co-founder of Cornbread Hemp and the US Hemp Roundtable, joins Bryan Fields and Kellan Finney to unpack Texas Governor Greg Abbott's veto of SB3, the state's proposed near-total THC ban,… Markdown: https://www.dimepodcast.com/episodes/trump-texas-sb3-the-rescheduling-timeline-jim-higdon-on-what-comes-next.md - [Fix the Process: Real Cannabis Manufacturing Tools & Optimization Techniques ft.: Murphy Murri](https://www.dimepodcast.com/episodes/fix-the-process-real-cannabis-manufacturing-tools-optimization-techniques-ft-murphy-murri) — Murphy Murri: Cannabis manufacturing consultant Murphy Murri joins Bryan Fields and Kellan Finney to dig into why the industry still lacks agreed-upon best practices for safety, quality, and efficiency, and how… Markdown: https://www.dimepodcast.com/episodes/fix-the-process-real-cannabis-manufacturing-tools-optimization-techniques-ft-murphy-murri.md - [Big Tobacco Is Moving on Cannabis, the Global Strategy Is Unfolding, and Deepak Anand Reveals Where’s Next](https://www.dimepodcast.com/episodes/big-tobacco-is-moving-on-cannabis-the-global-strategy-is-unfolding-and-deepak-anand-reveals-wheres-next) — Deepak Anand: Global cannabis strategist Deepak Anand joins Bryan Fields and Kellan Finney to map out how Big Tobacco — British American Tobacco, Altria, Philip Morris International, and Japan Tobacco — is quietly… Markdown: https://www.dimepodcast.com/episodes/big-tobacco-is-moving-on-cannabis-the-global-strategy-is-unfolding-and-deepak-anand-reveals-wheres-next.md - [Why Cannabis Companies Must Face Reality, Make Hard Choices, and Follow the Data ft. AnnaRae Grabstein](https://www.dimepodcast.com/episodes/why-cannabis-companies-must-face-reality-make-hard-choices-and-follow-the-data-ft-annarae-grabstein) — AnnaRae Grabstein: AnnaRae Grabstein, founder of the cannabis strategy firm Wolf Meyer and co-host of the High Spirits podcast, joins Bryan Fields and Kellan Finney to argue that hemp and adult-use cannabis are… Markdown: https://www.dimepodcast.com/episodes/why-cannabis-companies-must-face-reality-make-hard-choices-and-follow-the-data-ft-annarae-grabstein.md - [How Leafwell is Disrupting Healthcare: The Data Doctors Can’t Ignore ft. Emily Fisher & Dr June Chin](https://www.dimepodcast.com/episodes/how-leafwell-is-disrupting-healthcare-the-data-doctors-cant-ignore-ft-emily-fisher-dr-june-chin) — Emily Fisher & Dr June Chin: Leafwell co-founder Emily Fisher and Dr. June Chin, a physician and vice chair of New York State's cannabis advisory board, explain how their telehealth platform has grown into a data-driven cannabis… Markdown: https://www.dimepodcast.com/episodes/how-leafwell-is-disrupting-healthcare-the-data-doctors-cant-ignore-ft-emily-fisher-dr-june-chin.md - [The Hard Thing About Hard Things: A Melody of Grit & Fortitude ft. Christina Betancourt Johnson](https://www.dimepodcast.com/episodes/the-hard-thing-about-hard-things-a-melody-of-grit-fortitude-ft-christina-betancourt-johnson) — Christina Betancourt Johnson: Christina Betancourt Johnson, CEO of Standard Wellness Maryland, joins The Dime to unpack what it actually took to build a vertically integrated cannabis company — from a 2017 licensing bet through a… Markdown: https://www.dimepodcast.com/episodes/the-hard-thing-about-hard-things-a-melody-of-grit-fortitude-ft-christina-betancourt-johnson.md - [Premium Should Mean Organic: How Jetty Extracts is Leading the Clean Cannabis Movement ft. Ron Gershoni](https://www.dimepodcast.com/episodes/premium-should-mean-organic-how-jetty-extracts-is-leading-the-clean-cannabis-movement-ft-ron-gershoni) — Ron Gershoni: Ron Gershoni, co-founder of Jetty Extracts, traces the brand's path from a self-funded, unlicensed San Diego side hustle in 2013 to one of the oldest and most recognized names in California cannabis… Markdown: https://www.dimepodcast.com/episodes/premium-should-mean-organic-how-jetty-extracts-is-leading-the-clean-cannabis-movement-ft-ron-gershoni.md - [We Don’t Want Legalization—We Want Decriminalization ft. Luna Stower](https://www.dimepodcast.com/episodes/we-dont-want-legalizationwe-want-decriminalization-ft-luna-stower) — Luna Stower: Cannabis activist and vape-industry veteran Luna Stower joins The Dime to argue that the industry's biggest failure has been chasing "legalization" and commercialization instead of decriminalization,… Markdown: https://www.dimepodcast.com/episodes/we-dont-want-legalizationwe-want-decriminalization-ft-luna-stower.md - [China Tariffs & The Next Era of Vapes: Impact on Supply Chains & Brands ft. Nick Kovacevich](https://www.dimepodcast.com/episodes/china-tariffs-the-next-era-of-vapes-impact-on-supply-chains-brands-ft-nick-kovacevich) — Nick Kovacevich: Nick Kovacevich, corporate relations director at vape hardware maker C-Cell and founder of Kush Bottles, joins The Dime to unpack how a China-based supply chain reshapes the vape industry under new… Markdown: https://www.dimepodcast.com/episodes/china-tariffs-the-next-era-of-vapes-impact-on-supply-chains-brands-ft-nick-kovacevich.md - [Why Cannabis Laws Are a Mess: The Politics and Bureaucracy with Jeff Guillot](https://www.dimepodcast.com/episodes/why-cannabis-laws-are-a-mess-the-politics-and-bureaucracy-with-jeff-guillot) — Jeff Guillot: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Jeff Guillot, a longtime New York government affairs and lobbying veteran now with MAD Global Strategy, to unpack why cannabis… Markdown: https://www.dimepodcast.com/episodes/why-cannabis-laws-are-a-mess-the-politics-and-bureaucracy-with-jeff-guillot.md - [Stop Ignoring Germany’s Massive Opportunity – Europe is Coming! ft. Jamie Pearson](https://www.dimepodcast.com/episodes/stop-ignoring-germanys-massive-opportunity-europe-is-coming-ft-jamie-pearson) — Jamie Pearson: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Jamie Pearson, president of New Holland Group and former CEO of Bhang, to unpack Germany's fast-evolving cannabis landscape… Markdown: https://www.dimepodcast.com/episodes/stop-ignoring-germanys-massive-opportunity-europe-is-coming-ft-jamie-pearson.md - [Navigating the Gray: The Legal Tightrope of Cannabis Risk & Compliance ft. Dan Shapiro](https://www.dimepodcast.com/episodes/navigating-the-gray-the-legal-tightrope-of-cannabis-risk-compliance-ft-dan-shapiro) — Dan Shapiro: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Dan Shapiro, EVP at Ascend Wellness Holdings, to unpack what it's really like practicing law inside a multi-state cannabis… Markdown: https://www.dimepodcast.com/episodes/navigating-the-gray-the-legal-tightrope-of-cannabis-risk-compliance-ft-dan-shapiro.md - [Chris Violas Breaks Down Blaze’s Software Infrastructure](https://www.dimepodcast.com/episodes/chris-violas-breaks-down-blazes-software-infrastructure) — Chris Violas: In this episode of The Dime, Blaze CEO Chris Violas traces his path from college soccer player and cannabis delivery operator to building one of the cannabis industry's leading point-of-sale and… Markdown: https://www.dimepodcast.com/episodes/chris-violas-breaks-down-blazes-software-infrastructure.md - [Inside Curio Wellness with Wendy Bronfein: Maryland vs. Missouri Cannabis Markets and Crohn’s Treatment](https://www.dimepodcast.com/episodes/inside-curio-wellness-with-wendy-bronfein-maryland-vs-missouri-cannabis-markets-and-crohns-treatment) — Wendy Bronfein: In this episode of The Dime, Curio Wellness co-founder Wendy Bronfein joins hosts Bryan Fields and Kellan Finney to trace her path from Baltimore television to launching one of Maryland's first… Markdown: https://www.dimepodcast.com/episodes/inside-curio-wellness-with-wendy-bronfein-maryland-vs-missouri-cannabis-markets-and-crohns-treatment.md - [Sundie Seefried: Bank Secrecy, Hemp vs. Cannabis Banking, and Credit Card Barriers – What You Need to Know for the Future](https://www.dimepodcast.com/episodes/sundie-seefried-bank-secrecy-hemp-vs-cannabis-banking-and-credit-card-barriers-what-you-need-to-know-for-the-future) — Sundie Seefried: In this episode of The Dime, Sundie Seefried, CEO and President of Safe Harbor Financial, shares how she built one of the first compliant cannabis banking programs in the U.S. starting in 2014, and… Markdown: https://www.dimepodcast.com/episodes/sundie-seefried-bank-secrecy-hemp-vs-cannabis-banking-and-credit-card-barriers-what-you-need-to-know-for-the-future.md - [Surprising Medical Uses of Cannabis: First-Hand Insights from Dr. Benjamin Caplan on Cancer, Dementia, and Skincare](https://www.dimepodcast.com/episodes/surprising-medical-uses-of-cannabis-first-hand-insights-from-dr-benjamin-caplan-on-cancer-dementia-and-skincare) — Dr. Benjamin Caplan: In this episode of The Dime, hosts Bryan Fields and Kellan Finney speak with Dr. Benjamin Caplan, a Boston-based primary care physician, founder of Seed Clinic, and author of the Doctor-Approved… Markdown: https://www.dimepodcast.com/episodes/surprising-medical-uses-of-cannabis-first-hand-insights-from-dr-benjamin-caplan-on-cancer-dementia-and-skincare.md - [Emily Sisneros: Kentucky's Hot Medical Market and Winning Cannabis Licenses](https://www.dimepodcast.com/episodes/emily-sisneros-kentuckys-hot-medical-market-and-winning-cannabis-licenses) — Emily Sisneros: In this episode of The Dime, hosts Bryan Fields and Kellan Finney talk with Emily Sisneros, a cannabis licensing attorney-turned-consultant and CEO of Canna Business Services, about her path from… Markdown: https://www.dimepodcast.com/episodes/emily-sisneros-kentuckys-hot-medical-market-and-winning-cannabis-licenses.md - [Behind the Scenes of Cannabis Lobbying: How it REALLY Works ft. The Liaison Group](https://www.dimepodcast.com/episodes/behind-the-scenes-of-cannabis-lobbying-how-it-really-works-ft-the-liaison-group) — Erin Moffet & David Mangone: This episode of The Dime features David Mangone and Erin of The Liaison Group, federal cannabis lobbyists representing the National Cannabis Roundtable, explaining how cannabis lobbying actually… Markdown: https://www.dimepodcast.com/episodes/behind-the-scenes-of-cannabis-lobbying-how-it-really-works-ft-the-liaison-group.md - [Can CBN Replace Melatonin? Results from a Double-Blind Placebo-Controlled Study ft. Alleh Lindquist](https://www.dimepodcast.com/episodes/can-cbn-replace-melatonin-results-from-a-double-blind-placebo-controlled-study-ft-alleh-lindquist) — Alleh Lindquist: This episode of The Dime features Alleh Lindquist, CEO of FlorWorks, discussing how his company built a proprietary, patented CBN compound ("True CBN") and ran a large double-blind,… Markdown: https://www.dimepodcast.com/episodes/can-cbn-replace-melatonin-results-from-a-double-blind-placebo-controlled-study-ft-alleh-lindquist.md - [New York's Broken Cannabis Program: What Happened and How to Fix It ft. Neil Kaufman](https://www.dimepodcast.com/episodes/new-yorks-broken-cannabis-program-what-happened-and-how-to-fix-it-ft-neil-kaufman) — Neil Kaufman: This episode of The Dime features cannabis attorney Neil Kaufman breaking down why New York's adult-use cannabis rollout has struggled so badly, from Governor Hochul's overhaul of the program to the… Markdown: https://www.dimepodcast.com/episodes/new-yorks-broken-cannabis-program-what-happened-and-how-to-fix-it-ft-neil-kaufman.md - [Building a Private Juggernaut: Efficiency at Every Step with Mario Naric](https://www.dimepodcast.com/episodes/building-a-private-juggernaut-efficiency-at-every-step-with-mario-naric) — Mario Naric: In this episode of The Dime, hosts Bryan Fields and Kellan Finney sit down with Mario Naric, CEO and founder of Motif Labs, a Canadian cannabis extraction and brand company built by a former… Markdown: https://www.dimepodcast.com/episodes/building-a-private-juggernaut-efficiency-at-every-step-with-mario-naric.md - [How Minor Cannabinoids are Made: Synthetic vs Biosynthetic ft. Shane Johnson](https://www.dimepodcast.com/episodes/how-minor-cannabinoids-are-made-synthetic-vs-biosynthetic-ft-shane-johnson) — Shane Johnson: This episode of The Dime features Shane Johnson, SVP and GM of BayMedica (a subsidiary of InMed Pharmaceuticals), explaining how minor and rare cannabinoids like CBC, CBN, and THCV are produced… Markdown: https://www.dimepodcast.com/episodes/how-minor-cannabinoids-are-made-synthetic-vs-biosynthetic-ft-shane-johnson.md - [Aaron Nosbisch Reveals BRĒZ Marketing Secrets: A Beverage Exploding Toward $20 Million](https://www.dimepodcast.com/episodes/aaron-nosbisch-reveals-brz-marketing-secrets-a-beverage-exploding-toward-20-million) — Aaron Nosbisch: This episode of The Dime features Aaron Nosbisch, founder of hemp-derived THC/CBD beverage brand BRĒZ, discussing how the company grew from an idea in January to $1.5 million cans sold and a $20… Markdown: https://www.dimepodcast.com/episodes/aaron-nosbisch-reveals-brz-marketing-secrets-a-beverage-exploding-toward-20-million.md - [Paul F. Austin on Exploring Psychedelics: Creativity, Hidden Benefits, Microdosing, and Retreats](https://www.dimepodcast.com/episodes/paul-f-austin-on-exploring-psychedelics-creativity-hidden-benefits-microdosing-and-retreats) — Paul F. Austin: This episode of The Dime features Paul F. Austin, founder of Third Wave and Synthesis, discussing the intersection of psychedelics, creativity, and leadership, including why many high-profile CEOs… Markdown: https://www.dimepodcast.com/episodes/paul-f-austin-on-exploring-psychedelics-creativity-hidden-benefits-microdosing-and-retreats.md - [Chris Fontes: Cannabis is Already Legal - Hemp vs Cannabis](https://www.dimepodcast.com/episodes/chris-fontes-cannabis-is-already-legal-hemp-vs-cannabis) — Chris Fontes: In this episode of The Dime, Chris Fontes, CEO of High Spirits Beverage and founder of Trojan Horse Cannabis, breaks down how the 2018 Farm Bill's 0.3% delta-9 THC threshold effectively created a… Markdown: https://www.dimepodcast.com/episodes/chris-fontes-cannabis-is-already-legal-hemp-vs-cannabis.md - [First-time Dispensary owner details his experience with the NY CAURD Program ft. Markel Bababekov](https://www.dimepodcast.com/episodes/first-time-dispensary-owner-details-his-experience-with-the-ny-caurd-program-ft-markel-bababekov) — Markel Bababekov: This episode of The Dime features Markel Bababekov, owner of The Herbal Care, a CAURD-licensed dispensary on Manhattan's Upper East Side, discussing his journey from cannabis processing in Los… Markdown: https://www.dimepodcast.com/episodes/first-time-dispensary-owner-details-his-experience-with-the-ny-caurd-program-ft-markel-bababekov.md - [Emergency Update: Shane Pennington Breaks Down Cannabis Rescheduling](https://www.dimepodcast.com/episodes/emergency-update-shane-pennington-breaks-down-cannabis-rescheduling) — Shane Pennington: This episode of The Dime features attorney Shane Pennington, partner at Porter Wright, breaking down the federal cannabis rescheduling process in granular detail — from HHS's recommendation and DEA's… Markdown: https://www.dimepodcast.com/episodes/emergency-update-shane-pennington-breaks-down-cannabis-rescheduling.md - [Paul Weaver of Boston Beer Company on Big Alcohol's Cannabis Strategy](https://www.dimepodcast.com/episodes/paul-weaver-of-boston-beer-company-on-big-alcohols-cannabis-strategy) — Paul Weaver: This episode of The Dime features Paul Weaver, head of cannabis at the Boston Beer Company, discussing how the maker of Sam Adams, Twisted Tea, Angry Orchard, and Truly built an asset-light cannabis… Markdown: https://www.dimepodcast.com/episodes/paul-weaver-of-boston-beer-company-on-big-alcohols-cannabis-strategy.md - [Do You Have Cannabis DNA? ft. Kmesh](https://www.dimepodcast.com/episodes/do-you-have-cannabis-dna-ft-kmesh) — Kmesh: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Kmesh, a cannabis industry career coach and founder of KmeshCan, who spent years as an executive recruiter at Flower Hire… Markdown: https://www.dimepodcast.com/episodes/do-you-have-cannabis-dna-ft-kmesh.md - [Willie McKenzie: From Legacy California to Profitable 8-Figure Cannabis Operation & Building the Elite Cannabis Operators Mastermind](https://www.dimepodcast.com/episodes/willie-mckenzie-from-legacy-california-to-profitable-8-figure-cannabis-operation-building-the-elite-cannabis-operators-mastermind) — Willie McKenzie: This episode of The Dime features Willie McKenzie, co-founder of Le Coast Holdings, who shares his journey from legacy California cannabis cultivation and personal hardship to building an 8-figure… Markdown: https://www.dimepodcast.com/episodes/willie-mckenzie-from-legacy-california-to-profitable-8-figure-cannabis-operation-building-the-elite-cannabis-operators-mastermind.md - [Are Drugs Bad, The Future Cannabinoids as a Medicine 3.0 ft. Dr. Matthew Moore](https://www.dimepodcast.com/episodes/are-drugs-bad-the-future-cannabinoids-as-a-medicine-30-ft-dr-matthew-moore) — Dr. Matthew Moore: In his record third appearance on The Dime, Dr. Matthew Moore joins hosts Bryan Fields and Kellen Finney for a wide-ranging conversation spanning the safety and misuse of psychedelics (sparked by the… Markdown: https://www.dimepodcast.com/episodes/are-drugs-bad-the-future-cannabinoids-as-a-medicine-30-ft-dr-matthew-moore.md - [Dr. Matthew Johnson: The World's Most Published Scientist on the Human Effects of Psychedelics](https://www.dimepodcast.com/episodes/dr-matthew-johnson-the-worlds-most-published-scientist-on-the-human-effects-of-psychedelics) — Dr. Matthew Johnson: This episode of The Dime features Dr. Matthew Johnson, a Johns Hopkins professor and one of the most published scientists studying the human effects of psychedelics, discussing his 20-year research… Markdown: https://www.dimepodcast.com/episodes/dr-matthew-johnson-the-worlds-most-published-scientist-on-the-human-effects-of-psychedelics.md - [Germany's Cannabis Landscape and the Impending Farm Bill Renewal: What you need to Know ft. Bob Hoban](https://www.dimepodcast.com/episodes/germanys-cannabis-landscape-and-the-impending-farm-bill-renewal-what-you-need-to-know-ft-bob-hoban) — Bob Hoban: In this episode of The Dime, hosts Bryan Fields and Kellen Finney sit down with cannabis attorney and global industry expert Bob Hoban of Clark Hill to unpack the upcoming Farm Bill renewal, the… Markdown: https://www.dimepodcast.com/episodes/germanys-cannabis-landscape-and-the-impending-farm-bill-renewal-what-you-need-to-know-ft-bob-hoban.md - [Matt Zorn: The Attorney Who Sued The DEA and Won](https://www.dimepodcast.com/episodes/matt-zorn-the-attorney-who-sued-the-dea-and-won) — Matt Zorn: In this episode of Dime, hosts Bryan Fields and Kellen Finney talk with attorney Matt Zorn of Yetter Coleman about his string of landmark lawsuits against the DEA on behalf of researcher Dr. Sue… Markdown: https://www.dimepodcast.com/episodes/matt-zorn-the-attorney-who-sued-the-dea-and-won.md --- Markdown variant of any episode, guest, newsletter, answer or topic page on this site: add .md to its URL. Site index: https://www.dimepodcast.com/llms.txt. Complete catalogue: https://www.dimepodcast.com/llms-full.txt